DK157845C - Analogifremgangsmaade til fremstilling af racemisk eller optisk aktiv n-(1'-allyl-2'-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid eller syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af racemisk eller optisk aktiv n-(1'-allyl-2'-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid eller syreadditionssalte deraf

Info

Publication number
DK157845C
DK157845C DK383081A DK383081A DK157845C DK 157845 C DK157845 C DK 157845C DK 383081 A DK383081 A DK 383081A DK 383081 A DK383081 A DK 383081A DK 157845 C DK157845 C DK 157845C
Authority
DK
Denmark
Prior art keywords
syntheride
pyrrolidinylmethyl
analogy
racemic
allyl
Prior art date
Application number
DK383081A
Other languages
Danish (da)
English (en)
Other versions
DK383081A (da
DK157845B (da
Inventor
Jacques Perrot
Michel Thominet
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of DK383081A publication Critical patent/DK383081A/da
Publication of DK157845B publication Critical patent/DK157845B/da
Application granted granted Critical
Publication of DK157845C publication Critical patent/DK157845C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
DK383081A 1980-08-28 1981-08-28 Analogifremgangsmaade til fremstilling af racemisk eller optisk aktiv n-(1'-allyl-2'-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid eller syreadditionssalte deraf DK157845C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8018635A FR2489327B1 (fr) 1980-08-28 1980-08-28 N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament
FR8018635 1980-08-28

Publications (3)

Publication Number Publication Date
DK383081A DK383081A (da) 1982-03-01
DK157845B DK157845B (da) 1990-02-26
DK157845C true DK157845C (da) 1990-07-23

Family

ID=9245444

Family Applications (1)

Application Number Title Priority Date Filing Date
DK383081A DK157845C (da) 1980-08-28 1981-08-28 Analogifremgangsmaade til fremstilling af racemisk eller optisk aktiv n-(1'-allyl-2'-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid eller syreadditionssalte deraf

Country Status (41)

Country Link
US (2) US4405636A (it)
EP (1) EP0047207B1 (it)
JP (1) JPS5775969A (it)
KR (1) KR840002063B1 (it)
AR (1) AR226737A1 (it)
AT (1) ATE11911T1 (it)
AU (1) AU549396B2 (it)
BE (1) BE890085A (it)
BG (1) BG36931A3 (it)
CA (1) CA1168250A (it)
CH (1) CH648299A5 (it)
CS (1) CS223895B2 (it)
DD (1) DD202011A5 (it)
DE (2) DE3133768A1 (it)
DK (1) DK157845C (it)
EG (1) EG15376A (it)
ES (1) ES8301466A1 (it)
FI (1) FI73207C (it)
FR (1) FR2489327B1 (it)
GB (1) GB2083033B (it)
GR (1) GR74560B (it)
HK (1) HK55989A (it)
HU (1) HU183555B (it)
IE (1) IE51357B1 (it)
IL (1) IL63217A (it)
IN (1) IN155495B (it)
IS (1) IS1213B6 (it)
IT (1) IT1171490B (it)
JO (1) JO1120B1 (it)
LU (1) LU83583A1 (it)
MA (1) MA19218A1 (it)
MX (1) MX6707E (it)
NO (1) NO155097C (it)
OA (1) OA06877A (it)
PH (1) PH19211A (it)
PL (1) PL135397B1 (it)
PT (1) PT73509B (it)
SU (1) SU1148559A3 (it)
YU (1) YU42581B (it)
ZA (1) ZA814575B (it)
ZW (1) ZW17581A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317597D0 (en) * 1983-06-29 1983-08-03 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525M (fr) * 1961-07-25 1962-11-16 Ile De France Médicaments antiémétiques nouveaux.
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (it) * 1966-01-21 1968-05-06
US3766178A (en) * 1967-04-03 1973-10-16 Ile De France Substituted 2-arylalkyloxy benzamides
GB1364231A (en) 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (it) * 1973-09-25 1980-06-27 Ile De France
CH605793A5 (it) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative

Also Published As

Publication number Publication date
JO1120B1 (en) 1982-07-10
ZW17581A1 (en) 1981-10-21
FI73207C (fi) 1987-09-10
LU83583A1 (fr) 1981-12-01
BE890085A (fr) 1982-02-26
DE3133768A1 (de) 1982-06-16
GR74560B (it) 1984-06-29
CH648299A5 (fr) 1985-03-15
GB2083033B (en) 1984-02-01
EG15376A (en) 1986-12-30
EP0047207B1 (fr) 1985-02-20
DK383081A (da) 1982-03-01
YU201081A (en) 1983-10-31
KR830006201A (ko) 1983-09-20
SU1148559A3 (ru) 1985-03-30
EP0047207A1 (fr) 1982-03-10
IE51357B1 (en) 1986-12-10
MX6707E (es) 1985-10-23
JPS5775969A (en) 1982-05-12
US4405636A (en) 1983-09-20
IT1171490B (it) 1987-06-10
GB2083033A (en) 1982-03-17
ES503805A0 (es) 1982-12-01
DK157845B (da) 1990-02-26
NO155097C (no) 1987-02-11
AU549396B2 (en) 1986-01-23
IL63217A (en) 1985-03-31
FI812506L (fi) 1982-03-01
ZA814575B (en) 1982-07-28
AR226737A1 (es) 1982-08-13
PH19211A (en) 1986-02-04
CS223895B2 (en) 1983-11-25
NO812937L (no) 1982-03-01
IE811449L (en) 1982-02-28
DD202011A5 (de) 1983-08-24
AU7464281A (en) 1982-03-04
OA06877A (fr) 1983-04-30
IS1213B6 (is) 1986-04-02
PT73509A (fr) 1981-09-01
NO155097B (no) 1986-11-03
IS2654A7 (is) 1981-09-11
IN155495B (it) 1985-02-09
MA19218A1 (fr) 1982-04-01
PL135397B1 (en) 1985-10-31
IT8149179A0 (it) 1981-08-26
CA1168250A (fr) 1984-05-29
ATE11911T1 (de) 1985-03-15
ES8301466A1 (es) 1982-12-01
PT73509B (fr) 1982-10-28
BG36931A3 (en) 1985-02-15
HK55989A (en) 1989-07-21
KR840002063B1 (ko) 1984-11-09
HU183555B (en) 1984-05-28
US4550179A (en) 1985-10-29
IL63217A0 (en) 1981-10-30
YU42581B (en) 1988-10-31
JPH0233027B2 (it) 1990-07-25
FI73207B (fi) 1987-05-29
FR2489327A1 (fr) 1982-03-05
PL232686A1 (it) 1982-03-01
DE3169052D1 (en) 1985-03-28
FR2489327B1 (fr) 1984-05-18

Similar Documents

Publication Publication Date Title
DK538981A (da) Fremgangsmaade til styring af elektrostatisk stoevudskillers arbejdsparametre
DK127982A (da) Fremgangsmaade til fremstilling af flercycliske forbindelser eller salte,estre eller amider deraf
ES506222A0 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
PT72435B (pt) Process for the preparation of 2-<2-(1,4-benzodioxanyl)>-2-imi-dazoline and salts thereof having pharmaceutical effect
DK435082A (da) Fremgangsmaade til fremstilling af benzamider
DK118482A (da) Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf
DK160935C (da) Fremgangsmaade til fremstilling af optisk aktive alkyl-2-chlorpropionater
DK185579A (da) Fremgangsmaade til fremstilling af n-(benzothienopyrazol)amider
DK576784A (da) Fremgangsmaade til fremstilling af optisk aktive 3-aminocarboxylsyreestere
MX6163E (es) Metodo para la preparacion de n-(trimetoxibencil)-n'-fenil-piperazinas
DK161195C (da) Fremgangsmaade til fremstilling af bisallylcarbonater af dioler
DK157845C (da) Analogifremgangsmaade til fremstilling af racemisk eller optisk aktiv n-(1'-allyl-2'-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid eller syreadditionssalte deraf
DK150902C (da) Analogifremgangsmaade til fremstilling af n-(3-alkylaminopropyl)-n'-(disubstitueret)-phenylurinstoffer
DK247181A (da) Fremgangsmaade til fremstilling af n-(cykloalkyl)- aminosyreforbindelser
DK46685D0 (da) Optisk aktiv substitueret butyramid, og fremgangsmaade til den optiske adskillelse af substitueret butyramid
DK40781A (da) Fremgangsmaade til fremstilling af cycliske benzamidderivater
DK66579A (da) Fremgangsmaade til fremstilling af et optisk aktivt benzamid
ES507893A0 (es) Procedimiento para la preparacion de nuevas n-(p-aminofenil)-n'--benzoilureas substituidas .
DK350283D0 (da) Fremgangsmade til fremstilling af optisk aktive forbindelser
AR230275A1 (es) Un procedimiento para la preparacion de n-(2-((5-dimetilamino)metil-2-furanilmetil)tio)etil)-n'-metil-2-nitro-1 1-etenodiamina(ranitidina)
NO814074L (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider
ES502121A0 (es) Metodo para la preparacion de n-(2-(((5-dialquilamino)-me- til-2-metil-2-furanil)-metil)-etil)-n'alquil-2-nitro-1,1- etendiamina
DK159144C (da) Fremgangsmaade til fremstilling af optisk aktive aryloxyalkansyrederivater
ES489341A0 (es) Metodo para la preparacion de n-((alcoxicarbonil)(alquil)a- minosulfenil)fosforamidotioatos
DK144784A (da) Optiske antipoder af 8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemiddel

Legal Events

Date Code Title Description
PBP Patent lapsed